The Business Research Company’s Viral Vectors And Plasmid DNA Global Market Report 2021: COVID-19 Implications And Growth To 2030
LONDON, GREATER LONDON, UK, June 10, 2021 /EINPresswire.com/ — According to the new market research report ‘Viral Vectors And Plasmid DNA Global Market Report 2021: COVID-19 Implications And Growth To 2030’ published by The Business Research Company, the global viral vectors & plasmid DNA market is expected to grow from $0.55 billion in 2020 to $0.64 billion in 2021 at a compound annual growth rate (CAGR) of 16.4%. The growth is mainly due to the outbreak of COVID-19 and requires targeted delivery of the drug to treat affected patients. The number of cases has been increasing resulting in a surge in demand for viral vectors & plasmid DNA. The viral vectors & plasmid DNA market is expected to reach $1.34 billion in 2025 at a CAGR of 20%. The rise in the global incidence of cancer is driving the viral vector & plasmid DNA market.
Request For A Sample For The Global Viral Vectors And Plasmid DNA Market Report:
The viral vectors & plasmid DNA market consists of sales of viral vectors and plasmid DNA and related services. The viral vectors & plasmid DNA are used for the delivery of cellular therapies, like gene therapy and immunotherapy, and also for treating some viral infections. The viral vectors & plasmid DNA are used for formulation development in research and development labs. The viral vectors are genetically engineered viruses carrying viral RNA or DNA that is non-infectious but still contain viral promoters and transgene. The plasmid DNA is a double-stranded extra chromosomal and circular DNA sequence that is capable of replication using the host cell’s replication system.
Trends In The Global Viral Vectors And Plasmid DNA Market
Mergers and acquisitions are expected to create a platform for the life cycle management of cell and gene therapy products. In January 2020, Cognate Bioservices Inc, a US-based company skilled in cell and cell-mediated gene therapy products, acquired Cobra Biologics, specialized in providing manufacturing services for plasmid DNA and viral vector, for an undisclosed amount. The acquisition is expected to create a platform for the life cycle management of cell and gene therapy products. Cobra biologics is well established in the development and manufacture of a variety of viral vectors and DNA. The combined Cognate and Cobra expertise is expected to push both the businesses to a better position to respond to current and future market demand.
Global Viral Vectors And Plasmid DNA Market Segments:
The global viral vectors and plasmid DNA market is further segmented based on product, application, disease, end user and geography.
By Product: Plasmid DNA, Viral Vectors
By Application: Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Others
By Disease: Infectious Diseases, Genetic Disorders, Cancer, Others
By End User: Research Institutes, Biopharmaceutical And Pharmaceutical Companies
By Geography: The global viral vectors and plasmid DNA market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Viral Vectors And Plasmid DNA Market At:
Viral Vectors And Plasmid DNA Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides viral vectors and plasmid DNA market overviews, analyzes and forecasts market size and growth for the global viral vectors and plasmid DNA market, viral vectors and plasmid DNA market share, viral vectors and plasmid DNA market players, viral vectors and plasmid DNA market segments and geographies, viral vectors and plasmid DNA market’s leading competitors’ revenues, profiles and market shares. The viral vectors and plasmid DNA market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Read Viral Vectors And Plasmid DNA Global Market Report 2021 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Viral Vectors And Plasmid DNA Market Organizations Covered: FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Viral Vectors And Plasmid DNA Global Market Report 2021:
Gene Editing Global Market Report 2021: COVID-19 Growth And Change To 2030
Microbiology Diagnostic Devices And Equipment Global Market Report 2021: COVID-19 Implications And Growth To 2030
Bioinformatics Global Market Report 2021: COVID-19 Growth And Change To 2030
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293